Skip to content

Clinical trials

Hypertension trials in Japan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hypertension Country / region: Japan Clear all

138 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20035
20049
20056
200615
200711
20085
20095
201011
201111
201210
20135
20144
20154
20164
20174
20181
20212
20223
20233
20245
20258
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed96
Unknown status18
Recruiting9
Terminated7
Active, not recruiting6
Withdrawn2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim15
Novartis Pharmaceuticals15
Takeda9
Bayer7
Novartis7
Daiichi Sankyo Co., Ltd.5
Eli Lilly and Company5
AstraZeneca4
Jichi Medical University4
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hypertension138
Cardiovascular Diseases16
Diabetes Mellitus, Type 214
Essential Hypertension12
Renal Insufficiency, Chronic9
Diabetes Mellitus8
Coronary Artery Disease6
Vascular Diseases6
Obesity5
Albuminuria4

Trials

Showing 51 to 75 of 138. Each trial links to its page on Pharma Observatory.

38 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.